Lipoprotein (a) and apolipoprotein e ε4 as independent risk factors for ischemic stroke

European Journal of Preventive Cardiology

Volumn 6, Issue 1, 1999, Pages 1-6

  Peng, Dao Quan ^a   Zhao, Shui Ping ^a   Wang, Jia Liang ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b SCHOOL OF BASIC MEDICAL SCIENCES   (China)

Author keywords

apolipoprotein E; ischemic stroke; lipoprotein; risk factor

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; STROKE;

AGED; ALCOHOL DRINKING; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; LIKELIHOOD FUNCTIONS; LINEAR MODELS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING;

EID: 84992884199     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748739900600101     Document Type: Article

References (40)

1. World Health Organization Annual 1990. Geneva: World Health Organization; 1991. pp. 326–366.
2. Kussi T, Nieminen MS, Ehnholm C, Yki-Jarvinen H, Valle M, Nikkila EA, et al Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis 1989; 9: 237–241.
3. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, Ferrell RE, et al Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993; 71: 160–165.
4. Tiret L, de Knijff P, Menzel HJ, Ehnholm C, Nicaud V, Havekes LM, for the European Atherosclerosis Research (EARS) Study Group. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. Arterioscler Thromb 1994; 14: 1617–1624.
5. Pedro-Botet J, Senti M, Nogués X, Rubies-Prat J, Roquer J, D'Olhaberriague L, et al Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein (a) triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992; 23: 1556–1562.
6. Couderc R, Mahieux F, Bailleul S. Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimer's disease. Stroke 1994; 24: 1416–1417.
7. Coria R, Rubio I, Nuñez E, Sempere AP, Engracia N Santa, Bayon C, et al Apolipoprotein E variants in ischemic stroke [letter]. Stroke 1995; 26: 2375–2376.
8. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995; 15: 1280–1286.
9. Iso H, Jacobs DR, Wentworth D, Neaton JD. Serum cholesterol levels and six-year mortality from stroke in 350 977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904–910.
10. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglyceride on risk of cerebrovascular disease: the Copenhagen City heart study. BMJ 1994; 309: 11–15.
11. Chen Z, Collins R, Peto R. Serum cholesterol levels and stroke mortality. N Engl J Med 1989; 321: 1339–1440.
12. Quiziblash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischemic attacks and minor ischemic strokes. BMJ 1991; 303: 605–609.
13. Sidharam R. Risk factors for ischemic stroke: a case control analysis. Neuroepidemiology 1992; 11: 24–30.
14. Woo J, Lao E, Lam CWK, Kay R, Teoh R, Wong HY, et al Hypertension, lipoprotein (a) and apolipoprotein A-1 as risk factors for stroke in the Chinese. Stroke 1991; 22: 203–208.
15. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxford Community Stroke Project. Stroke 1987; 18: 545–551.
16. McNamara Jr., Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987; 166: 1–8.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
18. Marcovina SM, Albers JJ, Dati F, Ledue TB, Ritchie RF. International federation of clinical chemistry standardization project for measurement of apolipoprotein A-1 and B. Clin Chem 1991; 37: 1676–1682.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545–548.
20. Hollanders FD, Shafar J, Burton P. Serum lipid changes following the completed stroke syndrome. Postgraduate Medical Journal 1975; 51: 386–389.
21. Frank JW, Reed DM, Grove RS, Benfante R. Will lowering population levels of serum cholesterol affect total mortality? J Clin Epidemiol 1992; 45: 333–346.
22. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee D-J, Sherwin R, et al Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992; 152: 1490–1500.
23. Konishi M, Iso H, Komachi Y, lida M, Shimamoto T, Jacobs DR, et al Association of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: the Akita pathology study. Stroke 1993 24: 954–964.
24. Smith GD, Shipley MJ, Marmoto MG, Rose G. Plasma cholesterol concentration and mortality. JAMA 1992; 267: 70–76.
25. Stemmermann GN, Chyou PH, Kagan A, Nomura AMY, Yano K. Serum cholesterol and mortality among Japanese American men: the Honolulu (Hawaii) Heart Program. Arch Intern Med 1991; 151: 969–972.
26. Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol 1990; 131: 579–588.
27. Couderc R, Mahieux F, Bailleu S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case–control study. Stroke 1993; 24: 661–664.
28. Rhoads GG, Dahlén G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540–2544.
29. Scanu AM. Lipoprotein (a): a genetic risk factor for premature coronary heart disease. JAMA 1992; 267: 3326–3329.
30. Seed M, Hoppchler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E, et al Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990; 322: 1494–1499.
31. Ridker PM, Stampfer MJ, Hennekens CH. Plasma concentration of lipoprotein (a) and the risk of future stroke. JAMA 1995; 273: 1269–1273.
32. Nagayama M, Shinohara Y, Nagayama T. Lipoprotein (a) and ischemic cerebrovascular disease in young adults. Stroke 1994; 25: 74–78.
33. Shintani S, Kikuchi S, Hamaguchi H, Shiiai T. High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction. Stroke 1993; 24: 965–969.
34. McLean JW, Tomlinson JE, Kuang W-J, Eaton D, Chen EY, Fless GM, et al cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 300: 132–137.
35. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein (a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 1996; 27: 1044–1049.
36. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, et al Apolipoprotein E polymorphism and stroke in population sample aged 75 years or more. Stroke 1996; 27: 1310–1315.
37. Seist G, Pillot T, Régis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, et al Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068–1086.
38. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Harskamp FV, et al Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in Rotterdam study. Lancet 1997; 349: 151–154.
39. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoprotein in the population of Rochester, Minnesota. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991; 49: 1156–1166.
40. Terry JG, Howard G, Mercuri M, Bond MG, Crouse JR III. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima–media thickening. Stroke 1996; 27: 1755–1759.